Page last updated: 2024-10-31

mitotane and Cancer of Prostate

mitotane has been researched along with Cancer of Prostate in 3 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raja Gabaglia, C1
Diaz de Durana, Y1
Graham, FL1
Gauldie, J1
Sercarz, EE1
Braciak, TA1
Matveeva, SA1
Barsel', VA1
Evseenko, LS1
Newmark, SR1
Dluhy, RG1
Bennett, AH1

Other Studies

3 other studies available for mitotane and Cancer of Prostate

ArticleYear
Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Cancer research, 2007, Mar-01, Volume: 67, Issue:5

    Topics: Adenoviridae; Animals; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Genes, MHC Class

2007
[Change in the excretion of adrenal steroids as dependent on the chlodithane (2,4'-DDD) concentration in the blood of oncological patients].
    Voprosy onkologii, 1976, Volume: 22, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Adrenal Cortex Hormones; Adrenal Glands;

1976
Ectopic adrenocorticotropin syndrome with prostatic carcinoma.
    Urology, 1973, Volume: 2, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Adrenocorticotropic Hormone; Blood Gluco

1973